Actively Recruiting
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Led by Children's Hospital Medical Center, Cincinnati · Updated on 2025-07-17
200
Participants Needed
1
Research Sites
362 weeks
Total Duration
On this page
Sponsors
C
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
U
University of Connecticut
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.
CONDITIONS
Official Title
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Medical records from pregnant women with Sickle Cell Disease before June 20, 2019, including those who miscarried, had stillbirth, or completed labor at any stage
- Hydroxyurea exposure during pregnancy and/or breastfeeding
- Available information about pregnancy and breastfeeding outcomes for babies with and without hydroxyurea exposure from these women
You will not qualify if you...
- Missing or unavailable medical records or lack of information about hydroxyurea exposure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229
Actively Recruiting
Research Team
T
Teresa Latham
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here